Streetbeat News

Analyst Ratings

AJG

BMRN

BNTX

CHWY

FDX

KSPI

MUSA

NVO

RIVN

SMMT

Several large-cap stocks experienced significant declines last week. Notable losers include Summit Therapeutics, Kaspi.kz, BioMarin Pharmaceutical, Rivian Automotive, FedEx, BioNTech, Arthur J. Gallagher, Chewy, Novo Nordisk, and Murphy USA. Factors such as financial results, analyst reports, and competitive pressures contributed to these declines.

Portfolio Pulse from Lekha Gupta

September 22, 2024 | 9:04 pm

AAPL

BIDU

Apple's iPhone 16 launch shows strong demand, with Wedbush analyst Daniel Ives maintaining an Outperform rating and a $300 price target for Apple. The analyst predicts a robust upgrade cycle and significant sales in China, potentially driving Apple to a $4 trillion market cap by 2025.

Portfolio Pulse from Shanthi Rexaline

September 22, 2024 | 7:45 pm

AAPL

FDX

HD

PLTR

SKX

WMT

Benzinga highlights bullish and bearish stock stories, including Palantir's growth potential, Walmart's wage increase, and concerns over Apple's iPhone 16 demand. The Federal Reserve's rate cut raises stagflation fears.

Portfolio Pulse from Michael Cohen

September 21, 2024 | 12:11 pm

ADMA

Analysts have provided mixed ratings for ADMA Biologics, with a recent increase in the average 12-month price target to $18.25. The company shows strong financial health with significant revenue growth and profitability metrics exceeding industry averages.

Portfolio Pulse from Benzinga Insights

September 20, 2024 | 9:01 pm

RNST

In the past three months, 10 analysts have rated Renasant (NYSE:RNST), with most being indifferent. The average 12-month price target has increased to $36.9, with a high of $41.00 and a low of $32.00. Analysts have adjusted their ratings and price targets, reflecting changing market conditions and company performance. Renasant shows strong financial health with a high net margin and ROE, but its revenue growth lags behind industry peers.

Portfolio Pulse from Benzinga Insights

September 20, 2024 | 9:01 pm

CATY

Cathay General (NASDAQ:CATY) has been analyzed by four analysts, showing a range of perspectives from somewhat bullish to somewhat bearish. The average 12-month price target has increased by 11.95% to $44.5. Despite a revenue decline of 12.76%, Cathay General maintains a strong net margin and effective asset utilization.

Portfolio Pulse from Benzinga Insights

September 20, 2024 | 9:01 pm

FFIN

Analysts have provided mixed evaluations for First Financial Bankshares (NASDAQ:FFIN) over the past three months, with a focus on price targets and ratings. The average 12-month price target has increased by 9.77% to $36.5. Analysts have adjusted their ratings and price targets, reflecting their response to market conditions and company performance. First Financial Bankshares has shown strong financial performance with a 7.11% revenue growth rate, a net margin of 40.04%, and effective debt management.

Portfolio Pulse from Benzinga Insights

September 20, 2024 | 9:00 pm

LOB

Analysts have mixed views on Live Oak Bancshares (NYSE:LOB) with recent ratings showing a shift towards bullish sentiment. The average 12-month price target has increased by 13.15% to $47.33. The company shows strong financial health with a positive revenue trend and efficient cost management.

Portfolio Pulse from Benzinga Insights

September 20, 2024 | 9:00 pm

RF

Analysts have varied opinions on Regions Financial (NYSE:RF), with recent ratings showing a mix of bullish and indifferent sentiments. The average 12-month price target has increased to $23.67, with a high of $28.00 and a low of $21.00. Despite revenue challenges, Regions Financial shows strong profitability and financial health.

Portfolio Pulse from Benzinga Insights

September 20, 2024 | 9:00 pm

V

Visa is experiencing a bearish trend in options trading, with 52% of trades being bearish. Significant investors are targeting a price range of $230 to $300. The stock is currently down 0.43% at $284, with analysts providing mixed ratings and price targets ranging from $308 to $319.

Portfolio Pulse from Benzinga Insights

September 20, 2024 | 8:47 pm